Literature DB >> 12631643

Management of TIPS-related refractory hepatic encephalopathy with reduced Wallgraft endoprostheses.

David C Madoff1, Irene V Perez-Young, Michael J Wallace, Mark D Skolkin, Barry D Toombs.   

Abstract

The purpose of this study is to evaluate the feasibility of constrained endografts used for the treatment of transjugular intrahepatic portosystemic shunt (TIPS)-related refractory hepatic encephalopathy (HE). Because the clinical status of two patients worsened (return of intractable ascites requiring transplantation, n = 1; death, n = 1) after complete balloon occlusion, six patients were treated with constrained/modified Wallgraft endoprostheses placed within the preexisting TIPS. Shunt reductions were technically successful in all six patients, as shown by an immediate mean portosystemic gradient increase of 9.3 mm Hg. Clinical improvement was achieved in five patients within 72 hours of reduction. The remaining patient continued to decline and died 3 weeks later. Two endografts completely occluded within 8 months without HE recurrence. This technique offers an attractive alternative to previously described shunt reduction methods.

Entities:  

Mesh:

Year:  2003        PMID: 12631643     DOI: 10.1097/01.rvi.0000058418.01661.48

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  6 in total

1.  Emergent stent occlusion for TIPS-induced liver failure.

Authors:  David C Wolf; Saima Siddiqui; Yaser Rayyan; Grigory Rozenblit
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

2.  Transjugular intrahepatic portosystemic shunt-related complications and practical solutions.

Authors:  Renato Ripamonti; Hector Ferral; Marc Alonzo; Nilesh H Patel
Journal:  Semin Intervent Radiol       Date:  2006-06       Impact factor: 1.513

3.  Reduced stents and stent-grafts for the management of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation.

Authors:  David C Madoff; Michael J Wallace
Journal:  Semin Intervent Radiol       Date:  2005-12       Impact factor: 1.513

4.  Transjugular intrahepatic portosystemic stent shunt (TIPSS) modification in the management of post-TIPSS refractory hepatic encephalopathy.

Authors:  N Kochar; D Tripathi; H Ireland; D N Redhead; P C Hayes
Journal:  Gut       Date:  2006-03-29       Impact factor: 23.059

5.  Effect of underdilated transjugular intrahepatic portosystemic shunt on prognosis in patients with prior splenectomy: a propensity score-matched case-control study.

Authors:  Wei Yao; Jia-Cheng Liu; Yong-Juan Wu; Chong-Tu Yang; Shu-Guang Ju; Ying-Liang Wang; Chao-Yang Wang; Song-Jiang Huang; Yao-Wei Bai; Yang Chen; Tong-Qiang Li; Chen Zhou; Bin Xiong
Journal:  Abdom Radiol (NY)       Date:  2022-07-12

6.  Potential Benefits of Underdilation of 8-mm Covered Stent in Transjugular Intrahepatic Portosystemic Shunt Creation.

Authors:  Jiacheng Liu; Jinqiang Ma; Chen Zhou; Chongtu Yang; Songjiang Huang; Qin Shi; Bin Xiong
Journal:  Clin Transl Gastroenterol       Date:  2021-06-18       Impact factor: 4.488

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.